Trial Profile
Treosulfan oral versus intravenous in recurrent ovarian cancer. An open-label, randomized, controlled, phase 3-b clinical trial - Treosulfan in ovarian cancer (IOM 10 / 01)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Treosulfan (Primary) ; Treosulfan (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions
- 25 Jan 2013 New trial record